Detection of dyslipidemias and use of lipid-lowering medicine was examined in youth.
Lipid testing declined over time.
And yet more severe and moderate dyslipidemias were detected.
But pharmacotherapy did not increase.
The gap between detection and treatment deserves more investigation.